- Home
- SNGX vs ABTS Comparison
SNGX vs ABTS Comparison
Compare SNGX & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- ABTS
- Stock Information
- Founded
- SNGX 1987
- ABTS 2010
- Country
- SNGX United States
- ABTS Hong Kong
- Employees
- SNGX N/A
- ABTS N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- SNGX Health Care
- ABTS Technology
- Exchange
- SNGX Nasdaq
- ABTS Nasdaq
- Market Cap
- SNGX 10.1M
- ABTS 8.9M
- IPO Year
- SNGX 1987
- ABTS N/A
- Fundamental
- Price
- SNGX $2.92
- ABTS $4.21
- Analyst Decision
- SNGX Strong Buy
- ABTS
- Analyst Count
- SNGX 1
- ABTS 0
- Target Price
- SNGX $6.00
- ABTS N/A
- AVG Volume (30 Days)
- SNGX 10.0M
- ABTS 16.1K
- Earning Date
- SNGX 11-07-2025
- ABTS 08-13-2025
- Dividend Yield
- SNGX N/A
- ABTS N/A
- EPS Growth
- SNGX N/A
- ABTS N/A
- EPS
- SNGX N/A
- ABTS N/A
- Revenue
- SNGX N/A
- ABTS $7,037,156.00
- Revenue This Year
- SNGX N/A
- ABTS N/A
- Revenue Next Year
- SNGX N/A
- ABTS N/A
- P/E Ratio
- SNGX N/A
- ABTS N/A
- Revenue Growth
- SNGX N/A
- ABTS 31.69
- 52 Week Low
- SNGX $1.09
- ABTS $1.35
- 52 Week High
- SNGX $6.23
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- SNGX 51.64
- ABTS 57.01
- Support Level
- SNGX $2.58
- ABTS $3.40
- Resistance Level
- SNGX $3.11
- ABTS $4.52
- Average True Range (ATR)
- SNGX 0.22
- ABTS 0.37
- MACD
- SNGX -0.09
- ABTS 0.07
- Stochastic Oscillator
- SNGX 43.59
- ABTS 72.23
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.